Derek Maetzold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance

Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesCastle bioscienceCastle biosciencesDerek maetzoldNational comprehensive cancer networkCastle biosciences incAmerican joint committee on cancerAmerican society of clinical oncologyCm american joint committee on cancerClinical oncologyAnnual meetingSkin cancersAmerican joint committeePreferentially expressed antigenStaging manualMypath melanoma

Castle Biosciences IDgenetix® Test Receives 2024 MedTech Breakthrough Award for Best Overall Mental Health Solution

Castle Biosciences IDgenetix® Test Receives 2024 MedTech Breakthrough Award for Best Overall Mental Health Solution
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesDerek maetzoldSteve johanssonCastle bioscienceCastle biosciencesOverall mental health solutionTechnology solutionMental health americaCastle biosciences incMental health weekHealth fitnessMental health in americaPsych congressClinical administrationMental health monthOverall mental health

Castle Biosciences, Inc (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript May 4, 2024 Castle Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Castle Biosciences First Quarter 2024 Conference Call. As a remainder, today’s call […]

United statesDerek maetzoldFrank stokesMental health2024 castle biosciencesFrank stokesDerek maetzoldCastle biosciencesForward looking statements

Castle Biosciences Reports First Quarter 2024 Results

Q1 2024 revenue increased 74% over Q1 2023 to $73 million Q1 2024 total test reports increased 40% over Q1 2023 Raising full-year 2024 revenue guidance to $255-265 million from $235-240.

United statesCastle biosciencesDerek maetzoldProgram registriesMental healthSee the companySecurities exchangeCastle biosciences incNational cancer institute surveillanceNational comprehensive cancer networkAmerican joint committee on cancer staging manualMedicare contractorsDecisiondx melanoma classQuarter ended marchPath melanomaAdjusted gross margin

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesLas vegasCity of friendswoodNew yorkCastle biosciencesDavid cotterDeb girardJulie bainAnne ramseyCastle decisiondxOlga villaverdeMontel williamsDerek maetzoldMelanoma research foundationCancer foundationSkin cancer foundation